Effect of LPS on the permeability of the blood–brain barrier to insulin

[1]  P. Pekala,et al.  Tumor necrosis factor-alpha-induced insulin resistance in adipocytes. , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[2]  M. Mcdaniel,et al.  Tumor Necrosis Factor α-induced Pancreatic β-Cell Insulin Resistance Is Mediated by Nitric Oxide and Prevented by 15-Deoxy-Δ12,14-prostaglandin J2 and Aminoguanidine , 1999, The Journal of Biological Chemistry.

[3]  W. Banks,et al.  Adsorptive Endocytosis of HIV-1gp120 by Blood–Brain Barrier Is Enhanced by Lipopolysaccharide , 1999, Experimental Neurology.

[4]  F. Lenz,et al.  Nitric Oxide Modulates Endothelin 1-Induced Ca2+ Mobilization and Cytoskeletal F-Actin Filaments in Human Cerebromicrovascular Endothelial Cells , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  L. Forman,et al.  Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. , 1998, The Journal of laboratory and clinical medicine.

[6]  H. Schröder,et al.  Cyclic AMP mediates endothelial protection by nitric oxide. , 1998, Biochemical and biophysical research communications.

[7]  T. Minami,et al.  Penetration of cisplatin into mouse brain by lipopolysaccharide. , 1998, Toxicology.

[8]  W. Mayhan.  Effect of lipopolysaccharide on the permeability and reactivity of the cerebral microcirculation: role of inducible nitric oxide synthase , 1998, Brain Research.

[9]  A. Sporbert,et al.  Nitric oxide protects blood‐brain barrier in vitro from hypoxia/reoxygenation‐mediated injury , 1998, FEBS letters.

[10]  W. Banks,et al.  Transport of Insulin Across the Blood-Brain Barrier: Saturability at Euglycemic Doses of Insulin , 1997, Peptides.

[11]  J. T. Weber,et al.  Tumor Necrosis Factor-α: a Neuromodulator in the CNS , 1997, Neuroscience & Biobehavioral Reviews.

[12]  W. Banks,et al.  Effect of Diabetes Mellitus on the Permeability of the Blood–Brain Barrier to Insulin , 1997, Peptides.

[13]  Simon C Watkins,et al.  Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia. , 1997, Nitric oxide : biology and chemistry.

[14]  D. Schwartz,et al.  Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. , 1997, The Journal of clinical investigation.

[15]  K. Yamagata,et al.  Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain. , 1997, The American journal of physiology.

[16]  W. Mayhan.  Role of nitric oxide in histamine-induced increases in permeability of the blood–brain barrier , 1996, Brain Research.

[17]  W. Banks,et al.  Sequestration of Centrally Administered Insulin by the Brain: Effects of Starvation, Aluminum, and TNF-α , 1996, Hormones and Behavior.

[18]  K. Boje.  Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis , 1996, Brain Research.

[19]  William G. Stetler-Stevenson,et al.  Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window , 1995, Brain Research.

[20]  A. Kawabata.  Effect of Aminoguanidine on the Survival in Mice Treated with Lipopolysaccharide , 1995 .

[21]  F Joó,et al.  Exposure of tumor necrosis factor‐α to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin , 1995 .

[22]  W. Mayhan.  Role of nitric oxide in disruption of the blood-brain barrier during acute hypertension , 1995, Brain Research.

[23]  S. Woods,et al.  Intraventricular insulin enhances the meal-suppressive efficacy of intraventricular cholecystokinin octapeptide in the baboon. , 1995, Behavioral neuroscience.

[24]  M. Schwartz,et al.  Effect of Intracerebroventricular Insulin Infusion on Diabetic Hyperphagia and Hypothalamic Neuropeptide Gene Expression , 1995, Diabetes.

[25]  A. Mark,et al.  Intracerebroventricular insulin produces nonuniform regional increases in sympathetic nerve activity. , 1994, The American journal of physiology.

[26]  C. Lugnier,et al.  Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway , 1994, British journal of pharmacology.

[27]  E. Pettipher,et al.  Cyclooxygenase inhibitors enhance tumour necrosis factor production and mortality in murine endotoxic shock. , 1994, Cytokine.

[28]  S. Hoyer,et al.  Short-term or long-term intracerebroventricular (i.c.v.) infusion of insulin exhibits a discrete anabolic effect on cerebral energy metabolism in the rat , 1994, Neuroscience Letters.

[29]  C. Z. Zhu,et al.  Intraventricular Administration of Insulin and IGF-1 in Transient Forebrain Ischemia , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  C Cobelli,et al.  Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. , 1993, The Journal of clinical investigation.

[31]  W. Banks,et al.  Murine tumor necrosis factor alpha is transported from blood to brain in the mouse , 1993, Journal of Neuroimmunology.

[32]  S. Moncada,et al.  Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells. , 1992, Biochemical and biophysical research communications.

[33]  P. Kubes,et al.  Nitric oxide modulates microvascular permeability. , 1992, The American journal of physiology.

[34]  R. S. Emery,et al.  Food intake and serum insulin responses to intraventricular infusions of insulin and IGF-I , 1991, Physiology & Behavior.

[35]  P. Kubes,et al.  Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Woods,et al.  Seasonal changes in CSF insulin levels in marmots: insulin may not be a satiety signal for fasting in winter. , 1991, The American journal of physiology.

[37]  W. Scheld,et al.  Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. , 1991, The Journal of clinical investigation.

[38]  S. Woods,et al.  Intraventricular insulin reduces food intake and body weight of marmots during the summer feeding period , 1991, Physiology & Behavior.

[39]  R. Cotran,et al.  Cytokines and endothelial cell biology. , 1990, Physiological reviews.

[40]  W. Pardridge,et al.  Blood-brain barrier transcytosis of insulin in developing rabbits , 1987, Brain Research.

[41]  T. Lewellen,et al.  Quantitative Autoradiographic Evidence for Insulin Receptors in the Choroid Plexus of the Rat Brain , 1986, Diabetes.

[42]  W. Pardridge,et al.  Enhanced Insulin Binding to Blood-Brain Barrier In Vivo and to Brain Microvessels In Vitro in Newborn Rabbits , 1985, Diabetes.

[43]  D. Heistad,et al.  Permeability of blood-brain barrier to various sized molecules. , 1985, The American journal of physiology.

[44]  W. Pardridge,et al.  A Direct In Vitro Demonstration of Insulin Binding to Isolated Brain Microvessels , 1981, Diabetes.

[45]  P. Kara,et al.  Dynamic modulation of cerebral cortex synaptic function by nitric oxide. , 1998, Progress in brain research.

[46]  J. Stamler,et al.  Nitric oxide in the central nervous system. , 1994, Progress in brain research.

[47]  W. Banks,et al.  Physiological Consequences of the Passage of Peptides Across the Blood-Brain Barrier , 1993, Reviews in the neurosciences.

[48]  K. Feingold,et al.  The metabolic effects of tumor necrosis factor and other cytokines , 1991, Biotherapy.